Last Updated : June 28, 2007
Details
FilesGeneric Name:
Lanthanum carbonate hydrate
Project Status:
Complete
Therapeutic Area:
Hyperphosphatemia, end-stage renal disease
Manufacturer:
Shire BioChem Inc.
Brand Name:
Fosrenol
Project Line:
Reimbursement Review
Project Number:
SR0100-000
Submission Type:
Initial
Indications:
Hyperphosphatemia, end-stage renal disease
Recommendation Type:
Do not list
Final Recommendation:
Files
Last Updated : June 28, 2007